Stock CERT CERTARA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Certara, Inc.

Equities

CERT

US15687V1098

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
17.19 USD -0.87% Intraday chart for Certara, Inc. +1.72% -2.27%
Jun. 05 Transcript : Certara, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11:30 AM
May. 21 Certara, Inc Appoints Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Certara to Participate in the Jefferies Global Healthcare Conference
GL
Certara Appoints New Chief Human Resources Officer & General Counsel
GL
Certara Reports First Quarter 2024 Financial Results
GL
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
GL
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
GL
Certara Reports Fourth Quarter 2023 Financial Results
GL
Certara Reports Fourth Quarter 2023 Financial Results
AQ
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
GL
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
GL
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  
GL
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  
AQ
Certara Reports Third Quarter 2023 Financial Results
GL
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
GL
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
GL
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
AQ
Certara to Participate in Upcoming Investor Conferences
GL
Certara Simcyp™ Group Awarded Two New Grants from US FDA
GL
Certara Simcyp™ Group Awarded Two New Grants from US FDA
AQ
Certara Reports Second Quarter 2023 Financial Results
GL
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CERT Stock
  4. News Certara, Inc.
  5. Press Releases